Analysts Anticipate Markel Co. (MKL) Will Post Quarterly Sales of $1.58 Billion

Analysts predict that Markel Co. (NYSE:MKL) will post sales of $1.58 billion for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Markel’s earnings. The highest sales estimate is $1.66 billion and the lowest is $1.54 billion. Markel reported sales of $1.43 billion in the same quarter last year, which would suggest a positive year over year growth rate of 10.5%. The firm is expected to issue its next earnings report on Wednesday, February 14th.

On average, analysts expect that Markel will report full-year sales of $1.58 billion for the current financial year, with estimates ranging from $5.93 billion to $6.06 billion. For the next year, analysts expect that the firm will report sales of $6.39 billion per share, with estimates ranging from $6.12 billion to $6.81 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Markel.

Markel (NYSE:MKL) last released its quarterly earnings results on Wednesday, October 25th. The insurance provider reported ($18.82) EPS for the quarter, missing analysts’ consensus estimates of ($18.03) by ($0.79). Markel had a net margin of 1.60% and a return on equity of 0.83%.

A number of research analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Markel from a “hold” rating to a “buy” rating and set a $1,238.00 price target for the company in a research report on Friday. Royal Bank of Canada restated a “hold” rating and set a $1,050.00 price target on shares of Markel in a research report on Tuesday, October 3rd. SunTrust Banks restated a “hold” rating and set a $1,100.00 price target on shares of Markel in a research report on Friday, October 27th. Finally, Boenning Scattergood restated a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $1,109.50.

In related news, Vice Chairman Steven A. Markel sold 200 shares of the company’s stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $1,115.78, for a total value of $223,156.00. Following the completion of the transaction, the insider now directly owns 106,712 shares in the company, valued at $119,067,115.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $1,133.50, for a total transaction of $113,350.00. The disclosure for this sale can be found here. Insiders have sold a total of 2,307 shares of company stock valued at $2,535,956 over the last 90 days. Company insiders own 2.53% of the company’s stock.

A number of large investors have recently made changes to their positions in MKL. Comerica Bank grew its position in Markel by 1.4% in the second quarter. Comerica Bank now owns 590 shares of the insurance provider’s stock worth $603,000 after acquiring an additional 8 shares in the last quarter. Prudential Financial Inc. grew its position in Markel by 10.6% in the second quarter. Prudential Financial Inc. now owns 1,042 shares of the insurance provider’s stock worth $1,017,000 after acquiring an additional 100 shares in the last quarter. Neuberger Berman Group LLC grew its position in Markel by 0.5% in the second quarter. Neuberger Berman Group LLC now owns 428 shares of the insurance provider’s stock worth $418,000 after acquiring an additional 2 shares in the last quarter. JPMorgan Chase & Co. grew its position in Markel by 273.1% in the second quarter. JPMorgan Chase & Co. now owns 4,153 shares of the insurance provider’s stock worth $4,052,000 after acquiring an additional 3,040 shares in the last quarter. Finally, Schroder Investment Management Group purchased a new position in Markel in the second quarter worth $1,428,000. Institutional investors own 76.79% of the company’s stock.

Markel (NYSE:MKL) opened at $1,123.37 on Monday. The company has a market cap of $15,605.86, a price-to-earnings ratio of 249.64 and a beta of 1.04. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 0.28. Markel has a 1 year low of $612.00 and a 1 year high of $1,157.30.

TRADEMARK VIOLATION WARNING: “Analysts Anticipate Markel Co. (MKL) Will Post Quarterly Sales of $1.58 Billion” was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.com-unik.info/2018/01/15/analysts-anticipate-markel-co-mkl-will-post-quarterly-sales-of-1-58-billion.html.

About Markel

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Get a free copy of the Zacks research report on Markel (MKL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Markel (NYSE:MKL)

What are top analysts saying about Markel? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Markel and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit